Overcoming obstacles in pharmaceutical research
From securing a robust supply chain to encountering different comparator drug formulations, there are a swathe of variables…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Mar 12
From securing a robust supply chain to encountering different comparator drug formulations, there are a swathe of variables…
08 Mar 12
Logistics systems in the developed world continue to evolve at breakneck speed, but their counterparts in emerging nations…
01 Mar 12
The impending patent cliff will mean losses for Big Pharma, but gains for their generic competition. GBI Research’s…
01 Mar 12
As countries begin to recover from the effects of the recession, ICD Research’s latest report on the global…
01 Mar 12
The quantity of mergers and acquisitions is falling in the pharmaceutical and healthcare industry, but companies are responding…
01 Mar 12
How consumers look after their health has many implications for the pharmaceutical industry. Sheryl Coughlin reveals Deloitte’s latest…
01 Mar 12
European countries have been struggling with increasing pharmaceutical expenditure. Cost-containment is a major thrust area for policy reforms…
01 Mar 12
Given the complex manufacturing process of biopharmaceuticals, achieving operational excellence is an organisational challenge. To do this and…
31 Jan 12
Climate change has a huge effect on healthcare and the role that pharmaceutical manufacturers must play. But there…
31 Jan 12
The Innovative Medicines Initiative is planning to call for new proposals for major research projects, such as a…